Apex Meds Get started
All peptides

Wolverine Stack · Recovery & repair Two repair peptides.
One physician's plan.
Built around recovery.

BPC-157 and TB-500 prescribed together for people whose training is limited by how fast they recover. Evaluated by a licensed Apex Meds provider and filled by a licensed U.S. pharmacy.

$350per month · injectable
Apex Meds Wolverine Stack vial
Form
Subcutaneous injection
Course
A set cycle, then a break
Prescribed by
Licensed Apex Meds provider
Contains
BPC-157 and TB-500
What is Wolverine Stack?

Wolverine Stack, in plain terms

The Wolverine Stack is the common name for BPC-157 and TB-500 used together. The nickname comes from the comic-book character known for healing fast. It is a name, not a promise.

BPC-157 is a 15-amino-acid peptide modelled on a protective protein found in stomach fluid. TB-500 is a short synthetic fragment of thymosin beta-4, a protein present in nearly every human cell and concentrated in platelets and wound fluid.

What the research shows
What it has been studied for

The findings, and the kind of study behind each

Tendon and ligament

Thirty-five animal and lab studies of BPC-157 showed improved healing of muscle, tendon, ligament and bone.

Animal and lab

Wound closure

In rats, thymosin beta-4 sped skin wound closure, up 42% at day four and 61% at day seven.

Animal and lab

Knee pain

In a small series of knee-pain patients given BPC-157 into the joint, most reported improvement. No control group.

Early human

The pairing itself

No controlled human trial has tested the two together. One rat study found no added effect.

Not yet studied
Who asks about it

People who want to move better, for longer

Coming back from injury

People returning from a tendon, muscle or ligament setback, alongside their rehab.

Active lifestyles

People who train most days and want a physician-guided recovery plan.

A recurring sore spot

People with an ache that keeps returning, who have already had it checked.

Staying in the game

People who want to keep doing what they love for longer.

These describe the people who ask about Wolverine Stack, not results. A licensed provider decides whether it is appropriate for you.

How it works

What it does in the body

In laboratory and animal work, BPC-157 supports the growth of new blood vessels and the activity of the cells that rebuild tendon. Thymosin beta-4 regulates actin, the scaffolding that lets cells change shape and travel to injured tissue.

The two are paired on the reasoning that they act on different parts of repair. That is a mechanistic rationale. It has not been confirmed in people.

Blood vessels

BPC-157 supported new vessel growth in animal models

Cell migration

Thymosin beta-4 helps cells travel to injured tissue

Tendon cells

BPC-157 raised the activity of cells that rebuild tendon

What to expect

On the protocol

01

How it's taken

Small injections just under the skin over a set cycle, followed by a break. Your provider sets the dose, the schedule and the length of the cycle. It arrives already reconstituted by the pharmacy, so there is no powder to mix and nothing to measure out.

02

What people report

Patients commonly describe first changes in soreness or mobility within a few weeks. These are patient reports, not trial outcomes, and results are not guaranteed.

03

Keep your care team

Peptides are not a substitute for diagnosis, physical therapy or orthopaedic care. Tell your provider about any injury you are treating.

Why Apex Meds

A higher standard in peptide therapy

  • Reviewed by a licensed provider
  • Filled by a licensed U.S. pharmacy
  • Arrives reconstituted, ready to use
  • Made for human use, never “research only”
  • Medical support while you are on it
Start my evaluation
Frequently asked questions

Wolverine Stack questions, answered

Why is it called the Wolverine Stack?

It is a nickname borrowed from a comic-book character known for fast healing. It is not a medical term and should not be read as a promise.

Is the combination proven to work better than either peptide alone?

No. No human trial has tested the combination, and the one animal study that compared them found no added benefit from combining.

Is it FDA-approved?

No. Neither ingredient is FDA-approved. When prescribed it is a compounded medication, which has not been reviewed by the FDA for safety, effectiveness or quality.

How is it taken?

As small subcutaneous injections over a set cycle, with the schedule set by your provider.

What are the risks?

Injection-site reactions, headache, fatigue and nausea are the most reported. Long-term safety is unknown. Because both peptides support blood vessel growth, people with cancer or a history of cancer should not use them without their oncologist's clearance.

Can competitive athletes use it?

No. Both ingredients are prohibited at all times under World Anti-Doping Agency rules. Many collegiate, professional and military programs follow the same list.

What should I know before I start?

Your provider reviews your full history, so tell them about every medication and condition, including any history of cancer. Reported side effects: redness, swelling or itching at the injection site; headache; fatigue or lightheadedness; mild nausea; long-term safety has not been studied. Who should not use it: active cancer or any history of cancer without oncologist clearance; pregnancy or breastfeeding; anyone under 18; athletes subject to drug testing.

Keep looking

Other peptides from Apex Meds

Physician-prescribed peptide therapy

Start with Wolverine Stack

Answer a few questions. A licensed Apex Meds provider decides whether it is right for you.

  • Expert guidance
  • Personalised care
  • Ongoing support

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Prescription products require an online evaluation with a licensed medical professional, who will determine whether a prescription is appropriate. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality. Research cited on this site describes published studies and is not a claim about what any product will do for you. Individual results vary.

Sources
  1. Vasireddi et al., systematic review, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/
  2. Malinda et al., J Invest Dermatol, 1999. https://pubmed.ncbi.nlm.nih.gov/10469335/
  3. Lee & Padgett, 2021. https://pubmed.ncbi.nlm.nih.gov/34324435/
  4. Bicer et al., Joint Diseases and Related Surgery, 2026. https://pubmed.ncbi.nlm.nih.gov/42542926/
  5. FDA evaluation of BPC-157, 2026. https://www.fda.gov/media/193343/download